The PE Ratio as of September 2024 (TTM) for Regencell Bioscience Holdings Limited (RGC) is -18.58

According to Regencell Bioscience Holdings Limited’s latest financial reports and current stock price. The company's current PE Ratio is -18.58. This represents a change of -45.63% compared to the average of -34.17 of the last 4 quarters.

Regencell Bioscience Holdings Limited (RGC) Historical PE Ratio (quarterly & annually)

How has RGC PE Ratio performed in the past?

The mean historical PE Ratio of Regencell Bioscience Holdings Limited over the last ten years is -65.25. The current -18.58 PE Ratio has changed 2.75% with respect to the historical average. Over the past ten years (40 quarters), RGC's PE Ratio was at its highest in in the September 2017 quarter at 36.15. The PE Ratio was at its lowest in in the March 2014 quarter at -339.68.

Regencell Bioscience Holdings Limited (RGC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Regencell Bioscience Holdings Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Regencell Bioscience Holdings Limited (RGC) Average PE Ratio

How has RGC PE Ratio performed in the past?

The current PE Ratio of Regencell Bioscience Holdings Limited (RGC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Regencell Bioscience Holdings Limited (RGC) PE Ratio vs. Peers

How is RGC’s PE Ratio compared to its peers?

Regencell Bioscience Holdings Limited’s PE Ratio is less than Delta 9 Cannabis Inc. (-0.13), less than RAMM Pharma Corp. (0), less than City View Green Holdings Inc. (-1.11), less than Craftport Cannabis Corp. (-0.01), less than Speakeasy Cannabis Club Ltd. (-0.00), less than Procaps Group, S.A. (0.07), less than Silver Spike Investment Corp. (14.29), less than Eagle Pharmaceuticals, Inc. (5.10), less than Phibro Animal Health Corporation (324.20), less than Sunshine Biopharma, Inc. (-0.04), less than Cosmos Health Inc. (-0.89), less than AcelRx Pharmaceuticals, Inc. (-1.83), less than HEXO Corp. (-0.24), less than Prestige Consumer Healthcare Inc. (18.08), less than Collegium Pharmaceutical, Inc. (12.07), less than ANI Pharmaceuticals, Inc. (43.28), less than Procaps Group S.A. (4.69),

Build a custom stock screener for Regencell Bioscience Holdings Limited (RGC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regencell Bioscience Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Regencell Bioscience Holdings Limited (RGC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Regencell Bioscience Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.